Niacin and the Stamets Stack
An educational overview of the Stamets Stack — a popular microdosing protocol combining psilocybin, Lion's Mane mushroom, and niacin (vitamin B3) — covering its proposed mechanisms, dosing guidelines, and important safety considerations.
⚠️ Educational purposes only. Not medical or legal advice.
The Stamets Stack Explained
The Stamets Stack is a microdosing protocol proposed by mycologist Paul Stamets, combining three components: a sub-perceptual dose of psilocybin mushrooms, Lion's Mane mushroom (Hericium erinaceus), and niacin (vitamin B3). Stamets has publicly described this combination as potentially synergistic, suggesting that each ingredient may amplify the effects of the others in ways that promote neurological health and cognitive enhancement. While the stack has attracted significant popular interest, it is important to note that rigorous clinical evidence specifically validating the three-way combination remains limited as of 2026.
The theoretical basis for the stack draws on three distinct mechanisms. Psilocybin (after conversion to psilocin) is thought to promote neuroplasticity through serotonin 5-HT2A receptor agonism and upregulation of brain-derived neurotrophic factor (BDNF). Lion's Mane contains hericenones and erinacines, compounds that may stimulate nerve growth factor (NGF) synthesis. Niacin, in its flush-inducing form, acts as a vasodilator and is hypothesised to help transport the other compounds across the blood-brain barrier more efficiently — though this mechanism is debated among researchers.
Interest in the Stamets Stack has grown considerably within harm-reduction and personal development communities. Anecdotal reports frequently describe improvements in mood, creativity, and cognitive clarity. However, prospective users should understand that individual responses vary widely, that psilocybin remains a controlled substance in most jurisdictions, and that combining supplements always carries the possibility of interactions. Approaching the stack with caution, thorough research, and ideally medical oversight is strongly encouraged.
The Role of Niacin (Vitamin B3)
Niacin, or nicotinic acid, is a water-soluble B vitamin essential for cellular metabolism. It is a precursor to NAD+ (nicotinamide adenine dinucleotide), a coenzyme involved in hundreds of metabolic reactions, including DNA repair, energy production, and neurotransmitter synthesis. At pharmacological doses — typically 100 mg or more — niacin causes a well-known side effect called the "niacin flush": a temporary reddening and tingling of the skin caused by prostaglandin-mediated vasodilation in peripheral blood vessels.
In the context of the Stamets Stack, this vasodilatory effect is considered functionally important. Stamets has suggested that the flush-induced increase in peripheral and potentially central blood flow may help transport psilocin and Lion's Mane bioactive compounds more effectively to neural tissue. While the blood-brain barrier is regulated by mechanisms distinct from peripheral vasodilation, some researchers have noted that niacin's broader vascular effects could still contribute to neurological bioavailability in indirect ways. Independent verification of this specific mechanism is still lacking.
Beyond its proposed role in the stack, niacin has a long history as a therapeutic agent. It has been studied for lipid management, with high-dose niacin raising HDL cholesterol and lowering triglycerides. Niacin also plays a role in serotonin biosynthesis, since tryptophan — the amino acid precursor to both serotonin and psilocin — is also converted to niacin via the kynurenine pathway. This biochemical relationship has led to speculation that niacin supplementation could modulate the tryptophan pathway in ways that interact with psilocybin's effects, though this remains theoretical.
Dosing Protocols
Stamets has publicly described a general dosing approach for the stack, though he has noted that individual calibration is important. A commonly referenced protocol uses approximately 0.1 g of dried psilocybin mushrooms, 50–200 mg of Lion's Mane extract (or a larger amount of whole dried mushroom), and 100–200 mg of flush niacin. These doses are taken together on dosing days, with the schedule often following a 5 days on / 2 days off pattern, though many practitioners use the Fadiman protocol (one day on, two days off) or a 1-on/1-off schedule instead.
The niacin dose is critical: most practitioners recommend starting at 50 mg to gauge flush intensity and tolerance, then titrating upward. The flush itself — characterised by warmth, redness, and tingling — usually peaks within 20 to 30 minutes of ingestion and resolves within an hour. Some users find the flush uncomfortable or disruptive to daily functioning, while others consider it a manageable side effect. Taking niacin with food can reduce flush intensity, as can taking an aspirin 30 minutes beforehand (though aspirin itself carries considerations for certain individuals).
It is essential to distinguish between flush niacin (nicotinic acid) and non-flush or "flush-free" niacin (inositol hexanicotinate or nicotinamide). Proponents of the Stamets Stack argue that only flush niacin provides the vasodilatory mechanism considered important in the protocol. Non-flush forms may not produce the same peripheral vascular effects, though they retain niacin's metabolic functions. Nicotinamide (niacinamide), while another form of B3, behaves differently and is not considered a direct substitute in this context.
Safety Considerations
Niacin is generally well tolerated at supplemental doses but carries meaningful risks at higher amounts. Extended use of high-dose niacin (above 500 mg/day) has been associated with hepatotoxicity (liver damage), particularly with sustained-release forms. Even flush niacin at doses above 500 mg taken over months should ideally be monitored with periodic liver function tests. Individuals with pre-existing liver conditions, peptic ulcers, or gout should exercise particular caution, as niacin can exacerbate these conditions.
Niacin interacts with several medications, including statins (potentially increasing the risk of myopathy), diabetes medications (niacin can raise blood glucose), and anticoagulants. Individuals taking any prescription medications should consult a healthcare provider before adding niacin to their regimen. Pregnant or breastfeeding individuals should also avoid pharmacological doses of niacin unless specifically directed by a physician, as safety data at those doses is limited.
For the broader Stamets Stack, the most significant safety consideration relates to the legal status of psilocybin mushrooms, which are controlled in most countries. From a pharmacological standpoint, psilocybin and niacin do not share overlapping toxicity profiles, and no specific dangerous interaction between them has been documented at the doses used in microdosing. Nevertheless, individuals with personal or family histories of psychosis, bipolar disorder type I, or schizophrenia spectrum disorders should approach psilocybin with great caution, and the addition of any supplement does not mitigate this fundamental risk consideration.
Frequently Asked Questions
What exactly is the Stamets Stack?
The Stamets Stack is a microdosing protocol proposed by mycologist Paul Stamets that combines three components: a sub-perceptual dose of psilocybin mushrooms (typically around 0.1 g of dried material), Lion's Mane mushroom (Hericium erinaceus), and flush niacin (vitamin B3, typically 100–200 mg). Stamets has theorised that these three substances work synergistically to promote neurogenesis and neuroplasticity. The stack became widely discussed in psychedelic communities following Stamets' appearances on podcasts and interviews around 2019, though rigorous clinical research specifically on the three-way combination remains limited.
Why does niacin cause flushing and is it harmful?
The niacin flush is caused by the release of prostaglandins (particularly PGD2) from skin cells, which triggers vasodilation of peripheral blood vessels. This leads to redness, warmth, and tingling — typically on the face, neck, and upper chest. The flush usually begins within 15–30 minutes of ingestion, peaks around 30 minutes, and resolves within an hour. It is not dangerous for most healthy individuals, though it can be uncomfortable. Taking niacin with food or a small amount of aspirin beforehand can reduce the intensity. Persistent or severe flushing at normal doses warrants medical evaluation.
What is the difference between flush and non-flush niacin?
Flush niacin (nicotinic acid) is the form that causes the prostaglandin-mediated skin flushing. Non-flush niacin (often sold as "no-flush niacin") is typically inositol hexanicotinate, which releases nicotinic acid more slowly and produces minimal flushing. Nicotinamide (niacinamide) is another B3 form that does not cause flushing and behaves differently pharmacologically. In the context of the Stamets Stack, proponents specifically call for flush niacin (nicotinic acid), as the vasodilatory effect is considered a functionally important part of the protocol. Non-flush forms are not considered equivalent for this purpose, even though they share some of niacin's metabolic functions.
What does Lion's Mane mushroom do in the Stamets Stack?
Lion's Mane (Hericium erinaceus) is a culinary and medicinal mushroom that contains bioactive compounds called hericenones (found in the fruiting body) and erinacines (found in the mycelium). These compounds have been shown in laboratory and animal studies to stimulate the synthesis of nerve growth factor (NGF), a protein important for the maintenance and growth of neurons. In the context of the Stamets Stack, Lion's Mane is theorised to complement psilocybin's neuroplasticity-promoting effects by providing additional NGF support. Human clinical trials on Lion's Mane for cognitive health are still emerging, but existing data suggests it is generally safe and potentially beneficial for neurological function.
What are typical doses used in the Stamets Stack?
Commonly referenced doses include approximately 0.1 g of dried psilocybin mushrooms (adjusted individually; some use 0.05–0.3 g depending on mushroom potency), 50–200 mg of Lion's Mane extract or 500 mg to 1 g of whole dried Lion's Mane mushroom, and 100–200 mg of flush niacin (nicotinic acid). Beginners are advised to start at the lower end of each range — particularly for niacin (starting at 50 mg to assess flush tolerance) and psilocybin (starting at the lowest effective dose). These are illustrative figures discussed in harm-reduction contexts and should not be construed as medical prescriptions.
How does on-day vs off-day scheduling work for this stack?
Several scheduling protocols exist. The most commonly discussed for the Stamets Stack is a 5-days-on/2-days-off pattern (dosing Monday through Friday, resting on weekends). Others use the Fadiman protocol (1 day on, 2 days off), which was developed independently of the Stamets Stack but is adapted for use with it. Some practitioners take Lion's Mane daily regardless of dosing schedule, since it has no psychoactive properties, while reserving psilocybin and niacin for designated dosing days. The off days are considered important to prevent tolerance development to psilocybin and to allow neurological integration of any adaptation triggered during dosing days.
Who should avoid niacin supplementation?
Individuals who should exercise caution or avoid pharmacological doses of niacin include those with active liver disease or elevated liver enzymes, a history of peptic ulcers (niacin can increase stomach acid production), gout (niacin may raise uric acid levels), diabetes (niacin can impair insulin sensitivity and raise blood glucose), and low blood pressure (the vasodilatory effect may cause problematic drops in blood pressure). Individuals taking statins should also be cautious due to an elevated risk of muscle-related side effects (myopathy). Pregnant and breastfeeding individuals should avoid high-dose niacin. Anyone with concerns should consult a doctor before beginning supplementation.
Does niacin interact with any medications?
Yes, niacin has several clinically significant drug interactions. When combined with statins (e.g., atorvastatin, simvastatin), niacin increases the risk of myopathy and rhabdomyolysis. With antidiabetic medications, niacin can antagonise blood glucose control, potentially requiring dose adjustments. Niacin may enhance the blood pressure-lowering effects of antihypertensive drugs, increasing hypotension risk. It may also interact with anticoagulants (e.g., warfarin), potentially affecting clotting times. Additionally, aspirin (sometimes used to reduce niacin flushing) can itself interact with anticoagulants. Always disclose all supplements to prescribing physicians and pharmacists.
Where does the research stand on the Stamets Stack specifically?
As of 2026, there are no completed, peer-reviewed randomised controlled trials evaluating the Stamets Stack as a combined protocol. Research on each individual component exists separately: psilocybin has been studied in clinical trials for depression, anxiety, and addiction; Lion's Mane has been examined in small human trials for cognitive function; and niacin's pharmacology is extensively documented. The three-way synergy proposed by Stamets is a hypothesis based on plausible biological mechanisms, but it has not been formally tested as a unit. Some research institutions are beginning to incorporate combination approaches into study designs, but definitive clinical evidence for the specific Stamets Stack remains a future research question.
How long before effects of the Stamets Stack are noticed?
Anecdotal reports from practitioners of the Stamets Stack suggest that noticeable effects — if experienced — typically emerge after several weeks of consistent use, often in the range of two to four weeks. This aligns with known timelines for neuroplasticity-related changes and the gradual accumulation of Lion's Mane bioactives. Some individuals report subtle improvements in mood, focus, or creativity within the first week, while others notice nothing distinct for a month or longer. It is important to maintain realistic expectations: not all individuals experience noticeable subjective effects from microdosing, and placebo response rates in open-label self-administration settings are known to be substantial.